Adiponectin, insulin resistance and clinical expression of the metabolic syndrome in patients with Type 2 diabetes. (Q51496934)

5 April 2018

title

Adiponectin, insulin resistance and clinical expression of the metabolic syndrome in patients with Type 2 diabetes. (English)

1 reference

5 April 2018

0 references

0 references

1 reference

1 reference

Mojiminiyi OA

1

1 reference

5 April 2018

Abdella NA

series ordinal

2

1 reference

5 April 2018

Al Arouj M

series ordinal

3

1 reference

5 April 2018

Ben Nakhi A

series ordinal

4

1 reference

5 April 2018

language of work or name

English

0 references

publication date

6 June 2006

1 reference

5 April 2018

International Journal of Obesity

published in

1 reference

5 April 2018

volume

31

1 reference

5 April 2018

page(s)

213-220

1 reference

5 April 2018

issue

2

1 reference

5 April 2018

https://scigraph.springernature.com/pub.10.1038/sj.ijo.0803355

exact match

0 references

cites work

The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure<SUBTITLE>The JNC 7 Report</SUBTITLE>

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803355

Association of C-reactive protein with coronary heart disease risk factors in patients with type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803355

Plasma leptin concentration in patients with Type 2 diabetes: relationship to cardiovascular disease risk factors and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803355

Adiponectin concentrations are influenced by renal function and diabetes duration in Pima Indians with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803355

Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803355

Inflammatory markers, adiponectin, and risk of type 2 diabetes in the Pima Indian.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803355

Adiponectin: more than just another fat cell hormone?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803355

The role of the novel adipocyte-derived hormone adiponectin in human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803355

Do different dimensions of the metabolic syndrome change together over time? Evidence supporting obesity as the central feature

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803355

Physiological insulinemia acutely modulates plasma leptin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803355

Plasma insulin concentration is more tightly linked to plasma leptin concentration than is the body mass index.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803355

Hormonal regulation of adiponectin gene expression in 3T3-L1 adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803355

Secretion of adiponectin and regulation of apM1 gene expression in human visceral adipose tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803355

Differential regulation of adiponectin secretion from cultured human omental and subcutaneous adipocytes: effects of insulin and rosiglitazone

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803355

The effect of thiazolidinediones on plasma adiponectin levels in normal, obese, and type 2 diabetic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803355

Insulin decreases human adiponectin plasma levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803355

Adiponectin is not altered with exercise training despite enhanced insulin action

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803355

Plasma adiponectin concentrations do not increase in association with moderate weight loss in insulin-resistant, obese women

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803355

Adiponectin gene expression is inhibited by beta-adrenergic stimulation via protein kinase A in 3T3-L1 adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803355

PPARgamma ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803355

Adiponectin gene expression and secretion is inhibited by interleukin-6 in 3T3-L1 adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803355

Contribution of visceral fat accumulation to the development of coronary artery disease in non-obese men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803355

Two-hour insulin determination improves the ability of abdominal fat measurement to identify risk for the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803355

Oligomerization state-dependent activation of NF-kappa B signaling pathway by adipocyte complement-related protein of 30 kDa (Acrp30)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803355

Structure-function studies of the adipocyte-secreted hormone Acrp30/adiponectin. Implications fpr metabolic regulation and bioactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803355

Low-grade systemic inflammation and the development of type 2 diabetes: the atherosclerosis risk in communities study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803355

Can we apply the National Cholesterol Education Program Adult Treatment Panel definition of the metabolic syndrome to Asians?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803355

An evaluation of candidate definitions of the metabolic syndrome in adult Asian Indians

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803355

The metabolic syndrome--a new worldwide definition

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803355

The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803355

Are Kuwaitis getting fatter?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803355

7 January 2021

Metabolic syndrome scientific statement by the American Heart Association and the National Heart, Lung, and Blood Institute

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803355

7 January 2021

Comment on the provisional report from the WHO consultation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803355

7 January 2021

Standards of medical care in diabetes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803355

7 January 2021

[Validation of the Düsseldorfer screening tool: a trait-based approach to assess psychological distress of cancer patients]

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803355

7 January 2021

Physiological role of adipose tissue: white adipose tissue as an endocrine and secretory organ.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803355

7 January 2021

Identifiers

DOI

10.1038/SJ.IJO.0803355

1 reference

5 April 2018

Dimensions Publication ID

0 references

1 reference

5 April 2018